The RIVAWAR Trial and ACS Guidelines for LV Thrombus

Host Craig Beavers spoke with Arthur Allen, PharmD, for the latest updates from the RIVAWAR trial of rivaroxaban and a discussion of the newest Acute Coronary Syndrome Guidelines for left ventricular thrombus.

For more information:

• Management of Patients at Risk for and With Left Ventricular Thrombus: A Scientific Statement From the American Heart Association
• Anticoagulation Forum Rapid Resources LV Thrombus
• 2025 ACC/AHA Guidelines
• ACC 2025: Rivaroxaban Comparable to Warfarin in Left Ventricular Blood Clots